Trial Profile
A double blind, randomised trial of lusutrombopag in chronic liver disease patients with severe thrombocytopenia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Lusutrombopag (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 12 Dec 2015 New trial record